Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre-test counseling for hereditary cancer risk

被引:1
作者
Capasso, Alexandra [1 ,2 ,4 ]
Nehoray, Bita [2 ]
Gorman, Nicholas [1 ]
Quinn, Emily A. [1 ]
Bucio, Daiana [3 ]
Blazer, Kathleen R. [2 ]
机构
[1] Keck Grad Inst, Sch Pharm & Hlth Sci, Claremont, CA USA
[2] City Hope Natl Med Ctr, Div Clin Canc Genom, Duarte, CA USA
[3] Invitae Corp, Clin Consultat Serv, San Francisco, CA USA
[4] City Hope Natl Med Ctr, Duarte, CA 91010 USA
基金
美国国家卫生研究院;
关键词
education; genetic counseling; genetics services; risk assessment; service delivery models; PRIMARY-CARE PROVIDERS; SERVICE DELIVERY; NATIONAL SOCIETY; ERA; INFORMATION; MODELS; FUTURE; EXPERIENCES; FAMILIES; GENOMICS;
D O I
10.1002/jgc4.1887
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
As demand for genetic cancer risk assessment (GCRA) continues to increase, so does the sense of urgency to scale up efforts to triage patients, facilitate informed consent, and order genetic testing for cancer risk. The National Society of Genetic Counselors outlines the elements of informed consent that should be addressed in a GCRA session. While this practice resource aims to improve health equity, research on how well the elements of informed consent are implemented in practice is lacking. This retrospective and prospective mixed-methods study assessed how adequately the elements of informed consent are addressed during pre-test GCRA among 307 community clinicians (CC) and 129 cancer genetic counselors (GC), and barriers they face to addressing these elements. Results revealed that more than 90% of both cohorts consistently addressed components of at least 5 of the 10 elements of informed consent during a pre-test consultation. Technical aspects and accuracy of the test and utilization of test results were the most similarly addressed elements. Notably, GCs more often review the purpose of the test and who to test, general information about the gene(s), and economic considerations whereas CCs more often review alternatives to testing. Both cohorts reported psychosocial aspects of the informed consent process as the least adequately addressed element. Time constraints and patient-related concerns were most often cited by both cohorts as barriers to optimal facilitation of informed consent. Additional barriers reported by CCs included provider lack of awareness, experience, or education, and availability of resources and institutional support. Findings from this study may contribute to the development of alternative delivery models that incorporate supplementary educational tools to enhance patient understanding about the utility of genetic testing, while helping to mitigate the barrier of time constraints. Equally important is the use of this information to develop continuing education tools for providers.
引用
收藏
页数:18
相关论文
共 67 条
[51]   American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility [J].
Robson, Mark E. ;
Bradbury, Angela R. ;
Arun, Banu ;
Domchek, Susan M. ;
Ford, James M. ;
Hampel, Heather L. ;
Lipkin, Stephen M. ;
Syngal, Sapna ;
Wollins, Dana S. ;
Lindor, Noralane M. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (31) :3660-+
[52]   Physician preparedness for big genomic data: a review of genomic medicine education initiatives in the United States [J].
Rubanovich, Caryn Kseniya ;
Cheung, Cynthia ;
Mandel, Jess ;
Bloss, Cinnamon S. .
HUMAN MOLECULAR GENETICS, 2018, 27 (R2) :R250-R258
[53]   Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome [J].
Samadder, N. Jewel ;
Riegert-Johnson, Douglas ;
Boardman, Lisa ;
Rhodes, Deborah ;
Wick, Myra ;
Okuno, Scott ;
Kunze, Katie L. ;
Golafshar, Michael ;
Uson, Pedro L. S., Jr. ;
Mountjoy, Luke ;
Ertz-Archambault, Natalie ;
Patel, Neej ;
Rodriguez, Eduardo A. ;
Lizaola-Mayo, Blanca ;
Lehrer, Michael ;
Thorpe, Cameron S. ;
Yu, Nathan Y. ;
Esplin, Edward D. ;
Nussbaum, Robert L. ;
Sharp, Richard R. ;
Azevedo, Cindy ;
Klint, Margaret ;
Hager, Megan ;
Macklin-Mantia, Sarah ;
Bryce, Alan H. ;
Bekaii-Saab, Tanios S. ;
Sekulic, Aleksandar ;
Stewart, Keith A. .
JAMA ONCOLOGY, 2021, 7 (02) :230-237
[54]   Healthcare professionals' and patients' perspectives on consent to clinical genetic testing: moving towards a more relational approach [J].
Samuel, Gabrielle Natalie ;
Dheensa, Sandi ;
Farsides, Bobbie ;
Fenwick, Angela ;
Lucassen, Anneke .
BMC MEDICAL ETHICS, 2017, 18
[55]   Cancer Genetic Counseling-Current Practice and Future Challenges [J].
Schienda, Jaclyn ;
Stopfer, Jill .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (06)
[56]   Therapeutic Implications of Germline Testing in Patients With Advanced Cancers [J].
Stadler, Zsofia K. ;
Maio, Anna ;
Chakravarty, Debyani ;
Kemel, Yelena ;
Sheehan, Margaret ;
Salo-Mullen, Erin ;
Tkachuk, Kaitlyn ;
Fong, Christopher J. ;
Nguyen, Bastien ;
Erakky, Amanda ;
Cadoo, Karen ;
Liu, Ying ;
Carlo, Maria, I ;
Latham, Alicia ;
Zhang, Hongxin ;
Kundra, Ritika ;
Smith, Shaleigh ;
Galle, Jesse ;
Aghajanian, Carol ;
Abu-Rustum, Nadeem ;
Varghese, Anna ;
O'Reilly, Eileen M. ;
Morris, Michael ;
Abida, Wassim ;
Walsh, Michael ;
Drilon, Alexander ;
Jayakumaran, Gowtham ;
Zehir, Ahmet ;
Ladanyi, Marc ;
Ceyhan-Birsoy, Ozge ;
Solit, David B. ;
Schultz, Nikolaus ;
Berger, Michael F. ;
Mandelker, Diana ;
Diaz, Luis A. ;
Offit, Kenneth ;
Robson, Mark E. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (24) :2698-+
[57]   The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine [J].
Stoll, Katie ;
Kubendran, Shobana ;
Cohen, Stephanie A. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2018, 178 (01) :24-37
[58]   Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing [J].
Susswein, Lisa R. ;
Marshall, Megan L. ;
Nusbaum, Rachel ;
Postula, Kristen J. Vogel ;
Weissman, Scott M. ;
Yackowski, Lauren ;
Vaccari, Erica M. ;
Bissonnette, Jeffrey ;
Booker, Jessica K. ;
Cremona, M. Laura ;
Gibellini, Federica ;
Murphy, Patricia D. ;
Pineda-Alvarez, Daniel E. ;
Pollevick, Guido D. ;
Xu, Zhixiong ;
Richard, Gabi ;
Bale, Sherri ;
Klein, Rachel T. ;
Hruska, Kathleen S. ;
Chung, Wendy K. .
GENETICS IN MEDICINE, 2016, 18 (08) :823-832
[59]   Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 2020 [J].
Tiner, Jessica C. ;
Mechanic, Leah E. ;
Gallicchio, Lisa ;
Gillanders, Elizabeth M. ;
Helzlsouer, Kathy J. .
GENETICS IN MEDICINE, 2022, 24 (12) :2526-2534
[60]   Models of Service Delivery for Cancer Genetic Risk Assessment and Counseling [J].
Trepanier, Angela M. ;
Allain, Dawn C. .
JOURNAL OF GENETIC COUNSELING, 2014, 23 (02) :239-253